Alosetron

Drugs of Today

Volumn 36, Issue 9, 2000, Pages 595-607

  Mucke, H ^a   Cole, P ^a   Rabasseda, X ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; AZASETRON; BEMESETRON; CILANSETRON; CISPLATIN; CYCLOPHOSPHAMIDE; DIPHENOXYLATE; DOLASETRON MESILATE; DRUG METABOLITE; FABESETRON; FEDOTOZINE; GRANISETRON; ITASETRON; LERISETRON; LOPERAMIDE; LUROSETRON; MEBEVERINE; MENTHOL; MIRISETRON; ONDANSETRON; OTILONIUM BROMIDE; PALONOSETRON; RAMOSETRON; RICASETRON; SEROTONIN 3 ANTAGONIST; SPASMOLYTIC AGENT; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAMIFENACIN; ZATOSETRON;

CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; IRRITABLE COLON; NOCICEPTION; RECEPTOR BLOCKING; REVIEW; SEROTONIN SYNDROME; SEX DIFFERENCE; SMOOTH MUSCLE SPASM; TABLET FORMULATION; VISCERAL PAIN;

EID: 0033788340     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2000.36.9.593776     Document Type: Review

References (48)

1. Irritable bowel syndrome in the general population
2. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress
3. Irritable bowel syndrome: Which definitions are consistent?
4. Irritable bowel syndrome: Disease definition and symptom description
5. Towards positive diagnosis of the irritable bowel
6. Review article: Gender-related differences in functional gastrointestinal disorders
7. Alosetron: The discovery of a novel treatment for irritable bowel syndrome
8. One-year follow-up of newly diagnosed irritable bowel syndrome patients
9. Role of visceral afferent mechanisms in functional bowel disorders
10. Altered rectal perception is a biological marker of patients with irritable bowel syndrome
11. Role of opioid ligands in the irritable bowel syndrome
12. A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome
13. The κ agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome
14. 3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome
15. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: A prospective, randomized trial
16. Menthol-β-D-glucuronide: A potential prodrug for treatment of the irritable bowel syndrome
17. Otilonium bromide in irritable bowel syndrome: A double-blind, placebo-controlled, 15-week study
18. 3 receptors
19. 3-receptor antagonist, GR38032F
20. 3 receptor antagonists and anti-emetic mechanisms of action
21. Serotonin antagonists inhibit sennoside-induced fluid secretion and diarrhea
22. Stress and visceral perception
23. 3 receptor antagonists in the treatment of irritable bowel syndrome
24. Central 5-hydroxytryptaminergic function in irritable bowel syndrome
25. 3 receptor antagonist GR68755 prevents a scopolamine-induced cognitive impairment in the common marmoset
26. Effects of GR68755 on d-amphetamine-induced changes in mood, cognitive performance, appetite, food preference, and caloric and macronutrient intake in humans
27. The disposition of GR-68755 after oral administration to man
28. Biotransformation of alosetron: Mechanism of hydantoin formation
29. Radioimmunoassay for the determination of alosetron in human urine and saliva
30. Determination of alosetron in human plasma or serum by high-performance liquid chromatography with robotic sample preparation
31. 3 receptor antagonist
32. 3 antagonist on gastrointestinal transit in normal healthy volunteers
33. 3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: A segmental perfusion study
34. 3 antagonist, alosetron, in patients with carcinoid diarrhoea
35. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
36. 3 receptor antagonist
37. 3-receptor antagonist
38. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial
39. Inward currents in neurons from newborn guinea pig intestine: Mediation by 5-hydroxytryptamine type 3 receptors
40. 3 antagonists
41. 3 receptor antagonist
42. 3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat
43. Alosetron slows colonic transit in patients with irritable bowel syndrome (IBS)
44. Alosetron does not affect the visceral perception of gastric distension in healthy subjects
45. Review article: Clinical pharmacology of alosetron
46. 3 receptor antagonist, in female irritable bowel syndrome patients
47. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients